Reuters logo
1 年前
BRIEF-FDA grants Roche label extension for cobas EGFR mutation test
2016年9月29日 / 凌晨5点16分 / 1 年前

BRIEF-FDA grants Roche label extension for cobas EGFR mutation test

Sept 29 (Reuters) - Roche Holding AG

* FDA grants Roche label extension for cobas egfr mutation test v2 for use with plasma as a companion diagnostic for Tagrisso

* FDA approved a label extension of cobas egfr mutation test v2 for use with plasma samples as a companion diagnostic for Astra Zeneca's non-small cell lung cancer (nsclc) therapy Tagrisso Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below